Martin Currie LTD Danaher Corp Transaction History

Martin Currie LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$96.1 - $103.24 $3.97 Million - $4.27 Million	-41,320 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$85.26 - $94.62 $91,739 - $101,811	-1,076 Reduced 2.54%	41,320 $3.84 Million
Q3 2017 Nov 14, 2017	SELL	$79.29 - $88.45 $358,390 - $399,794	-4,520 Reduced 9.63%	42,396 $3.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	46,916	46,916 $3.96 Million

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Martin Currie LTD, based on Form 13F filings with the SEC.

Stay updated on Martin Currie LTD with notifications on news.